EPO and obesity due to melanocortin 4 receptor deficiency: The association of lower BMI and the level of ESA resistance confirmed in our study can also be observed in the opposite direction since it has been previously shown that EPO can suppress obesity in both pre-clinical [44] and clinical studies [45].